论医药行业商业贿赂犯罪的刑法规制

发布时间：2018-08-07 20:04

【摘要】：近年来,随着经济全球化的发展,我国市场化进程不断加快,市场主体日趋多元化,市场竞争日益激烈。在商业交易中经营者为了获得高额利润,无视市场规则大量采用贿赂等不正当竞争手段,商业贿赂甚至成为了一种“潜规则”。医药行业更是成为商业贿赂的重灾区,医药生产与经营企业为了销售产品,投入大量资金用于贿赂医务工作人员。医务工作人员为了个人利益,在临床诊断时,给患者开具价格高,回扣高的药品,严重损害了患者的切身利益。医院俨然成为了一个商业化场所,严重忽视了其应承担的社会责任。由于医药行业商业贿赂泛滥,引发了许多社会问题,如药价虚高、医患关系紧张、医药市场秩序混乱等,不但破坏了医药市场的经营环境,损害了医务工作人员的形象,而且给国家经济造成了损失,削弱了党和政府的公信力。目前,医药行业商业贿赂犯罪手段日趋多样化,如回扣、劳务费、性贿赂等,而且犯罪形式具有较强的隐蔽性,给案件的侦破带来很大阻力。由于立法具有滞后性的特点,我国现行《刑法》及相关司法解释对商业贿赂犯罪的规定存在一定缺失,难以有效规制目前医药行业中的犯罪行为。为了有效打击犯罪,净化医药市场环境,完善医药行业商业贿赂犯罪的刑法规制势在必行。本文整体上分为四个部分,采取提出问题,分析问题,解决问题的模式进行论述。首先,对医药行业商业贿赂犯罪进行界定,归纳出医药行业商业贿赂犯罪的概念,并且分析其特点以及危害。其次,对我国目前关于医药行业商业贿赂犯罪的刑事立法进行分析,指出存在的问题,主要从构成要件、罪名体系、罪状表述、刑罚设置几个方面进行阐述。再次,介绍美国、德国、日本、联合国反商业贿赂犯罪的立法及启示,为完善我国医药行业商业贿赂犯罪的刑法规制提供借鉴。最后,在借鉴域外立法的基础之上,针对我国刑法规制存在的问题,提出完善我国医药行业商业贿赂犯罪刑法规制的对策,分别从构成要件、罪名体系、罪状表述、刑罚设置四个方面进行论述。
[Abstract]:In recent years, with the development of economic globalization, the process of marketization in our country is speeding up, the main body of the market is becoming more and more diversified, and the market competition is becoming increasingly fierce. In order to obtain the high profit and ignore the market rules, the operators adopt unfair competition means such as bribery, and commercial bribery even becomes a kind of "hidden rules". Pharmaceutical industry has become the disaster area of commercial bribery, pharmaceutical production and management enterprises in order to sell products, a large amount of money to bribe medical staff. For personal benefit, medical workers prescribe high price and high rebate drugs to patients in clinical diagnosis, which seriously damages the vital interests of patients. The hospital has become a commercialized place, neglecting its social responsibility seriously. The proliferation of commercial bribery in the pharmaceutical industry has caused many social problems, such as high drug prices, tense doctor-patient relations, disorder in the pharmaceutical market, and so on. This has not only damaged the operating environment of the pharmaceutical market, but also damaged the image of the medical staff. And to the national economy caused losses, weakened the credibility of the party and government. At present, the means of commercial bribery in pharmaceutical industry are becoming more and more diversified, such as kickbacks, labor fees, sexual bribery, and the form of crime has a strong concealment, which brings great resistance to the detection of cases. Because the legislation has the characteristic of lag, the current Criminal Law of our country and the related judicial explanation have certain deficiency to the regulation of the commercial bribery crime, so it is difficult to effectively regulate the current criminal behavior in the pharmaceutical industry. In order to effectively crack down on crime, purify the market environment of medicine, perfect the criminal law regulation of the crime of commercial bribery in medicine industry, it is imperative. This paper is divided into four parts, taking the mode of problem raising, problem analysis and problem solving. Firstly, it defines the crime of commercial bribery in medicine industry, induces the concept of the crime of commercial bribery in medicine industry, and analyzes its characteristics and harm. Secondly, the author analyzes the current criminal legislation on the crime of commercial bribery in the pharmaceutical industry, and points out the existing problems, mainly from the elements, the charge system, the description of the crime, and the establishment of the penalty. Thirdly, it introduces the legislation and enlightenment of the United States, Germany, Japan and the United Nations against the crime of commercial bribery, so as to provide reference for perfecting the criminal law regulation of the crime of commercial bribery in the pharmaceutical industry of our country. Finally, on the basis of foreign legislation, aiming at the existing problems of the criminal law regulation in our country, the author puts forward the countermeasures to perfect the criminal law regulation of the commercial bribery crime in the medicine industry of our country, respectively from the constitution elements, the charge system, the crime description. Four aspects of penalty setting are discussed.
【学位授予单位】：吉林财经大学
【学位级别】：硕士
【学位授予年份】：2017
【分类号】：D924.392

【相似文献】